Supplement makers may get temporary reprieve from FDA inspections
Jan 13, 2022
Larisa Pavlick is quoted:
“Within the UNPA family, we understand that most responsible and reputable companies will remain on course, and we will continue to be vigilant with appropriate GMP practices…Let’s use this time, free of audits and inspections, to focus and get better.”
She continues:
“Is it dangerous now that the FDA is not in the field?” asked Pavlick, a former FDA investigator with the Denver District office. “Is it more dangerous than it was before? No, in my opinion, because reputable and responsible companies have always focused on compliance and quality as part of the values of the organization and commitment to consumers.”
She added, “Nobody’s going to stay in business if they have poor-quality products that are hurting people.”
Names PK Davé CEO of Sabinsa’s Consumer Goods Division February 3, 2025 Sabinsa, the multi-national health science company known for providing sustainable, natural,
Sirio Pharma Launches SirioSure Quality Assurance Initiative for Nutrition Products Comprehensive QA/QC program runs full product lifespan, from ingredient sourcing and data-informed development
